Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

454.38
-13.1700-2.82%
Pre-market: 444.32-10.0600-2.21%08:22 EDT
Volume:1.08M
Turnover:493.92M
Market Cap:59.56B
PE:-184.42
High:469.81
Open:469.17
Low:454.20
Close:467.55
52wk High:469.81
52wk Low:205.87
Shares:131.08M
Float Shares:126.15M
Volume Ratio:0.96
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4638
EPS(LYR):-2.1790
ROE:-257.82%
ROA:-2.63%
PB:237.68
PE(LYR):-208.52

Loading ...

Alnylam Pharma (ALNY) Gets a Hold from Cantor Fitzgerald

TIPRANKS
·
Jul 18

Alnylam Pharmaceuticals Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 17

Alnylam Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Jul 16

U.S. RESEARCH ROUNDUP-Airbnb, BlackRock, Veritex

Reuters
·
Jul 16

Alnylam Pharma (ALNY) Receives a Buy from Citi

TIPRANKS
·
Jul 14

Alnylam Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Jul 11

Alnylam price target raised to $359 from $336 at BofA

TIPRANKS
·
Jul 11

Alnylam price target raised to $404 from $364 at Citi

TIPRANKS
·
Jul 11

RBC Capital Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 08

Alnylam Pharmaceuticals Is Maintained at Buy by Jefferies

Dow Jones
·
Jul 08

RBC Raises Price Target on Alnylam Pharmaceuticals to $350 From $330, Keeps Outperform Rating

MT Newswires Live
·
Jul 07

Alnylam price target raised to $384 from $328 at Jefferies

TIPRANKS
·
Jul 07

Alnylam Pharmaceuticals' OXLUMO Receives Nationwide Funding in Canada for Treating Rare Genetic Disease PH1 in Both Children and Adults

Reuters
·
Jul 03

Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Roche Holding AG (OtherRHHVF)

TIPRANKS
·
Jun 30

Alnylam price target raised to $377 from $320 at Needham

TIPRANKS
·
Jun 26

Alnylam Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Jun 26

Alnylam Pharmaceuticals Is Maintained at Outperform by BMO Capital

Dow Jones
·
Jun 25

Alnylam Pharmaceuticals Promotes Pushkal Garg to Chief R&D Officer to Lead Integrated Innovation Efforts

Reuters
·
Jun 18

RBC Capital Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
Jun 13